Shanghai Branch of Alphamab Oncology was established in June 2018, and the office is located on the bustling Pudong Century Avenue. The Shanghai branch is mainly composed of colleagues from the clinical development department, including clinical operations, medical department, drug safety, data management, statistics and other function teams. In just two years, it has developed into a team of nearly 100 people. The team can scientifically support the formulation of clinical development strategies for the company's core products including KN046, KN026, KN052, and JSKN003, and conduct a series of clinical trials with high efficiency and high quality. The main directors in charge have many years of clinical development experience in multinational pharmaceutical companies.

Beijing Branch of Alphamab Oncology was established at the end of 2018 and is located in the prosperous International Trade Center district. Its main function is to support the company's clinical development and regulatory affairs. In two years, it has developed into a team of nearly 40 people. Beijing branch, jointly with Suzhou head office and Shanghai branch, undertake the clinical development of KN046, KN026, KN052, JSKN003 and other core products. It mainly includes the medical department, clinical operation department, data management and regulatory affairs etc.